How is Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route dosed?
Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route is typically given by a healthcare professional in a hospital or cancer treatment center. The injection is given subcutaneously (under the skin) in the stomach area. Before receiving this medicine, the patient usually receives at least one full dose of rituximab through an IV infusion. The specific dosing information may vary depending on the medical condition being treated, age, and other individual factors. It is essential to follow the instructions provided by a healthcare professional when administering this medication.
What is the dosage form of Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route?
The dosage form of Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route is a solution.
What medications are contraindication with Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route?
Electrolyte or fluid imbalance, kidney disease, and certain infections like cytomegalovirus, herpes simplex virus, hepatitis B and C, parvovirus B19, varicella zoster virus, and West Nile virus may cause side effects to become worse when using this medication. It is important to consult with a healthcare professional for proper guidance on contraindications and precautions.
How is Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route administered?
Rituximab and Hyaluronidase Human Recombinant Subcutaneous Route is administered by a healthcare professional as a shot under the skin in the stomach area. This medicine should only be given by or under the direct supervision of a doctor.